151 related articles for article (PubMed ID: 19061898)
1. Binding of a noncovalent inhibitor exploiting the S' region stabilizes the hepatitis C virus NS3 protease conformation in the absence of cofactor.
Gallo M; Pennestri M; Bottomley MJ; Barbato G; Eliseo T; Paci M; Narjes F; De Francesco R; Summa V; Koch U; Bazzo R; Cicero DO
J Mol Biol; 2009 Jan; 385(4):1142-55. PubMed ID: 19061898
[TBL] [Abstract][Full Text] [Related]
2. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
3. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
[TBL] [Abstract][Full Text] [Related]
4. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
[TBL] [Abstract][Full Text] [Related]
5. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
Tautz N; Kaiser A; Thiel HJ
Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
[TBL] [Abstract][Full Text] [Related]
6. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor.
Love RA; Parge HE; Wickersham JA; Hostomsky Z; Habuka N; Moomaw EW; Adachi T; Margosiak S; Dagostino E; Hostomska Z
Clin Diagn Virol; 1998 Jul; 10(2-3):151-6. PubMed ID: 9741640
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design.
Venkatraman S; Njoroge FG; Girijavallabhan VM; Madison VS; Yao NH; Prongay AJ; Butkiewicz N; Pichardo J
J Med Chem; 2005 Aug; 48(16):5088-91. PubMed ID: 16078825
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: the basis of the genotype 1b vs. 3a inhibitor potency shift.
Gallo M; Bottomley MJ; Pennestri M; Eliseo T; Paci M; Koch U; Bazzo R; Summa V; Carfì A; Cicero DO
Virology; 2010 Sep; 405(2):424-38. PubMed ID: 20630554
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease.
Zhu H; Briggs JM
Proteins; 2011 Aug; 79(8):2428-43. PubMed ID: 21633972
[TBL] [Abstract][Full Text] [Related]
10. The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease.
Ontoria JM; Di Marco S; Conte I; Di Francesco ME; Gardelli C; Koch U; Matassa VG; Poma M; Steinkühler C; Volpari C; Harper S
J Med Chem; 2004 Dec; 47(26):6443-6. PubMed ID: 15588076
[TBL] [Abstract][Full Text] [Related]
11. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
Sardana VV; Blue JT; Zugay-Murphy J; Sardana MK; Kuo LC
Protein Expr Purif; 1999 Aug; 16(3):440-7. PubMed ID: 10425166
[TBL] [Abstract][Full Text] [Related]
12. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
Barbato G; Cicero DO; Nardi MC; Steinkühler C; Cortese R; De Francesco R; Bazzo R
J Mol Biol; 1999 Jun; 289(2):371-84. PubMed ID: 10366511
[TBL] [Abstract][Full Text] [Related]
13. Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide.
Bianchi E; Urbani A; Biasiol G; Brunetti M; Pessi A; De Francesco R; Steinkühler C
Biochemistry; 1997 Jun; 36(25):7890-7. PubMed ID: 9201934
[TBL] [Abstract][Full Text] [Related]
14. Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.
Wyss DF; Arasappan A; Senior MM; Wang YS; Beyer BM; Njoroge FG; McCoy MA
J Med Chem; 2004 May; 47(10):2486-98. PubMed ID: 15115392
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR.
Archer SJ; Camac DM; Wu ZJ; Farrow NA; Domaille PJ; Wasserman ZR; Bukhtiyarova M; Rizzo C; Jagannathan S; Mersinger LJ; Kettner CA
Chem Biol; 2002 Jan; 9(1):79-92. PubMed ID: 11841941
[TBL] [Abstract][Full Text] [Related]
17. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
18. Internal cleavages of hepatitis C virus NS3 induced by P1 mutations at the NS3/4A cleavage site.
Hou X; Yang W; Zhao Y; Agarwal A; Huang M
Virology; 2009 Jan; 383(2):271-8. PubMed ID: 19036397
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors.
Dahl G; Arenas OG; Danielson UH
Biochemistry; 2009 Dec; 48(48):11592-602. PubMed ID: 19839643
[TBL] [Abstract][Full Text] [Related]
20. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
